For patients with pulmonary sarcoidosis, methotrexate is noninferior to prednisone with regard to the change from baseline to ...

Treatment practices in the U.S. show approximately 75% of diagnosed pulmonary sarcoidosis patients require treatment with ...

Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted ...

For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks ...

Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted ...

A new biologic drug has been given to a patient with pulmonary sarcoidosis for the first time. The drug, infliximab, was administered at the John Radcliffe Hospital, part of Oxford University ...

Brenan Cullimore had a rare genetic condition, Brugada syndrome, that led to cardiac arrest. His wife wants to raise awareness of CPR, AEDs in saving lives. In early March 2025, medical student ...

The (FSR) is pleased to announce the appointment of four new members to its Board of Directors: John Mockovciak ...

The Foundation for Sarcoidosis Research (FSR) is pleased to announce the appointment of four new members to its Board of ...

One of the most common symptoms of dangerously high blood pressure is a severe headache. This headache is usually sudden and intense, unlike normal headaches. It can feel like a pounding or ...

In a study led by a multinational team of experts, researchers at National Jewish Health and their collaborators in Colorado, ...